Pathogen-free isolation unit — Three years' experienceBr Med J 1969; 1 doi: https://doi.org/10.1136/bmj.1.5647.836 (Published 29 March 1969) Cite this as: Br Med J 1969;1:836
- M. Schneider,
- L. Schwarzenberg,
- J. L. Amiel,
- A. Cattan,
- J. R. Schlumberger,
- M. Hayat,
- F. De Vassal,
- Cl. Jasmin,
- Cl. Rosenfeld,
- G. Mathé
The results obtained during the first three years of a pathogen-free isolation unit containing five beds have shown that this type of unit can reduce the risk of infection in patients treated with intensive chemotherapy or in those who have granulocytopenia from various causes. It is suggested that treatment of cancer which involves these risks should be carried out routinely in sterile isolation units, and that it is urgent to build many more and much larger units.
↵* From the Institut de Cancérologie et d'Immunogénétique, Hôpital Paul-Brousse, 14 Avenue Paul-Vaillant-Couturier, 94-Villejuif, France.
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial